Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm	Recruiting	Phase 1 / Phase 2	2026-09-01		NCT07539155

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of Arkansas	76

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Arkansas for Medical Sciences	Little Rock	United States	218

Clinical trials